R. Kohnen

发表

Creatine monohydrate in myotonic dystrophy

H. Hautmann, H. Lochmüller, D. Pongratz, 2002, Journal of Neurology.

Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study.

H. Hautmann, Hanns Lochmüller, D. Pongratz, 2002, Journal of neurology.

[Guidelines for carrying out application studies in psychopharmacotherapy. "Phase IV Research" Study Group of the Society of Neuropsychopharmacology and Pharmacopsychiatry].

M. Philipp, M. Osterheider, R. Kohnen, 1994, Der Nervenarzt.

Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP).

M. Philipp, M. Osterheider, R. Kohnen, 1997, Pharmacopsychiatry.

PTCA: is surgical back-up necessary? The view of a surgeon and a lawyer.

B. Messmer, R. Kohnen, 1994, Journal of interventional cardiology.

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.

R. Kohnen, M. Philipp, R. Kohnen, 1999, BMJ.

Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitor.

G. Laux, A. Delini-Stula, M. Philipp, 1999, International journal of psychiatry in clinical practice.

Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults

M. Philipp, R. Kohnen, J. Tiller, 2000, European Neuropsychopharmacology.

Treatment of depression with atypical features: A meta-analytic approach

H. Möller, R. Mergl, U. Hegerl, 2006, Psychiatry Research.

Frequency of sexual dysfunction in depressed adults and impact on quality of life

M. Philipp, R. Kohnen, J. Tiller, 1999, European Neuropsychopharmacology.

A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction

O. Benkert, M. Philipp, R. Kohnen, 1993, International clinical psychopharmacology.

Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride. Results of a prospective, randomized, double-blind, placebo-controlled trial.

F. Horvath, R. Kohnen, L. Ebeling, 1998, Pharmacopsychiatry.

Zotepine Versus Placebo in the Treatment of Schizophrenic Patients with Stable Primary Negative Symptoms: A Randomized Double-Blind Multicenter Trial

H. Möller, M. Riedel, W. Fischer, 2004, Pharmacopsychiatry.

Defining tranquilizers operationally by non additive effect in experimental stress situations

R. Kohnen, G. Lienert, 2004, Psychopharmacology.

Moclobemide versus fluoxetine in the treatment of inpatients with major depression.

H. Kick, R. Kohnen, W. Gattaz, 1995, Journal of clinical psychopharmacology.

The effects of alcohol and caffeine on concentration test performance.

R. Kohnen, G. Lienert, I. Keuchel, 1979, Arzneimittel-Forschung.

The Effects of Valerian, Propranolol, and their Combination on Activation, Performance, and Mood of Healthy Volunteers under Social Stress Conditions

R. Kohnen, W. Oswald, 1988, Pharmacopsychiatry.

What happens to patients after the end of a clinical trial? Systematic follow-up observational study of an open moclobemide trial in major depression.

H. Gothe, R. Kohnen, M. Linden, 1997, Pharmacopsychiatry.